Intracerebral haemorrhages and oral anticoagulation in the North of Scotland

Scottish Medical Journal

Volumn 45, Issue 4, 2000, Pages 101-104

  Berwaerts, J ^a   Robb, O J ^a   Jeffers, T A ^a   Webster, J ^a  

^a ABERDEEN ROYAL INFIRMARY   (United Kingdom)

Author keywords

Computer tomography; Haemorrhage; Intracerebral; Intracranial haemorrhage; Mortality; Warfarin

Indexed keywords

ANTICOAGULANT AGENT; WARFARIN;

ANTICOAGULANT THERAPY; ARTICLE; BRAIN HEMATOMA; BRAIN HEMORRHAGE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MORTALITY; OUTPATIENT; RISK; UNITED KINGDOM;

EID: 0033794993     PISSN: 00369330     EISSN: None     Source Type: Journal    
DOI: 10.1177/003693300004500402     Document Type: Article

References (51)

1. Andcoagulant-related bleeding: Clinical epidemiology, prediction, and prevention
2. Epidemiology of intracerebral hemorrhage
3. Adjusted subcutaneous heparin versus warfarin sodium in the longterm treatment of venous thrombosis
4. Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis
5. Randomised comparison of Mo intensities of oral anticoagulant therapy after tissue heart valve replacement
6. Trial of different intensities of anticoagulation in patents with prosthetic heart valves
7. A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement
8. Optimal oral anticoagulant therapy in patients with mechanical heart valves
9. Risks of long-term oral anticoagulant therapy in elderly patients after myocardial infarction
10. A controlled comparison of aspirin and oral anticoagulants in prevention of death after myocardial infarction
11. The effect of warfarin on mortality and reinfarction after myocardial infarction
12. Effect of long-term oral anticoagulant treatment on mortality and cardiovascular morbidity after myocardial infaration
13. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation: The Copenhagen AFASAK Study
14. Preliminary report of the stroke prevention in atrial fibrillation study
15. The effect of low dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation
16. Canadian atrial fibrillation anticoagulartion (CAFA) study
17. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation
18. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke
19. Warfarin versus aspirin for prevention of thromboembdism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study
20. Hemorrhagic complications of long-term anticoagulant therapy for ischemic cerebral vascular disease
21. Major bleeding in outpatients, treated with warfarin: Incidence and prediction by factors known at the start of outpatient therapy
22. Bleeding complications to oral anticoagulant therapy: Multivariate analysis of 1010 treatment years in 551 outpatients
23. Risk factors for complications of chronic anticoagulation
24. Bleeding complications in oral anticoagulant therapy: An analysis of risk factors
25. Bleeding complications of oral anticoagulant treatment: An inception-cohort prospective collaborative study (ISCOAT)
26. Complications of long-term anticoagulation
27. Bleeding risks factors and management of bleeding complications after treatment with anticoagulants, specific antithrombins, thrombolytics, IIb-IIIa receptor blockers
28. Prognostic parameters in spontaneous intracerebral hematomas with special reference to anticoagulant treatment
29. Incidence rates of strokes in the eighties: The end of the decline in stroke?
30. Declining incidence and mortality of stroke?
31. Increasing incidence of stroke among Swedish women
32. Changing rates of stroke in the province of Quebec, Canada: 1981-1988
33. Changes in the incidence and mortality of intracerebral hemorrhage
34. Oral anticoagulants and intracranial hemorrhage: Facts and hypotheses
35. Subdural haematoma associated with long term oral anticoagulation
36. Intracranial traumatic and non-traumatic haemorrhagic complications of warfarin treatment
37. Intracerebral haemorrhage: Incidence and use of computed tomography
38. Subdural hematoma and oral anticoagulant therapy
39. The risk of intracerebral hemorrhage during oral anticoagulant treatment: A population study
40. Intracerebral hematomas during anticoagulant treatment
41. Anticoagulation-related intracranial extracerebral haemorrhage
42. Anticoagulant treatment as a risk factor for primary intracerebral haemorrhage
43. Risk factors for intracranial hemorrhage in outpatients taking warfarin
44. Anticoagulant-related intracerebral hemorrhage
45. Neurologische Komplikationen durch Antikoagulantien und Fibrinolytika
46. Intracerebral hematomas during anticoagulant treatment
47. Anticoagulant-related intracerebral hemorrhage
48. Anticoagulant-related intracranial haemorrhage
49. Conditions de survenue des accidents hemorragiques intracreniens des antivitamines
50. The risks of minor head injury in the warfarinised patient
51. Cost effectiveness of primary stroke prevention in atrial fibrillation: Swedish national perspective